Clinuvel Pharmaceuticals
CUV.AX
#6819
Rank
S$0.59 B
Marketcap
$11.87
Share price
-0.95%
Change (1 day)
-11.78%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2023: S$40.04 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are S$51.84 Million. In 2023 the company made an earning of S$40.04 Million, an increase over its 2022 earnings that were of S$31.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2023

Annual earnings

Year Earnings Change
2023S$40.04 M27.77%
2022S$31.34 M22.23%
2021S$25.64 M114.01%
2020S$11.98 M-29.03%
2019S$16.88 M32.76%
2018S$12.71 M75.24%
2017S$7.25 M-332.09%
2016-S$3.13 Million-70.52%
2015-S$10.61 Million53.56%
2014-S$6.91 Million-16.31%
2013-S$8.26 Million-37.85%
2012-S$13.28 Million-18%
2011-S$16.2 Million25.86%
2010-S$12.87 Million-21.79%
2009-S$16.45 Million-11.73%
2008-S$18.64 Million80.71%
2007-S$10.32 Million-2.86%
2006-S$10.62 Million-4.95%
2005-S$11.17 Million60.55%
2004-S$6.96 Million97.37%
2003-S$3.53 Million50.62%
2002-S$2.35 Million121.22%
2001-S$1.06 Million254.48%
2000-S$0.3 Million